Biology, asked by techmaniac2806, 1 year ago

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease

Answers

Answered by arnav134
0

Explanation:

(i) Raisins in beaker A with plain water will get swollen due to endosmosis while raisins in beaker B with concentrated sugar solution will get shrink due to exosmosis.

(ii) Plain water is hypotonic while concentrated sugar solution is hypertonic.

Answered by Anonymous
0

Hey!♥

____________________________

Median to time to second CMR was estimated as 7.3 months in re-treated patients. Conclusion: Loss of MMR is a practical and safe criterion for restarting therapy in patients with CML with prolonged CMR.

  • Hope it helps!
Similar questions